MLN0905, CAS 1228960-69-7

Product Description: MLN0905 is a potent, orally active Polo-like kinase 1 (PLK1) inhibitor. MLN0905 has inhibitory potency against PLK1 with an IC50 value of 2 nM. MLN0905 can be used for the research of cancer[1][2].

Applications: Cancer-Kinase/protease

Formula: C24H25F3N6S

References: [1]Duffey MO, et al. Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905). J Med Chem. 2012 Jan 12;55(1):197-208./[2]Shi JQ, et al. MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma. Mol Cancer Ther. 2012 Sep;11(9):2045-53.

CAS Number: 1228960-69-7

Molecular Weight: 486.56

Compound Purity: 99.94

Research Area: Cancer

Solubility: DMSO : ≥ 30 mg/mL

Target: Polo-like Kinase (PLK)

• Artikelnummer: MEXHY-15155-100
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-15155-100
• Green Labware: Nein
• Verpackungseinheit: 100 mg
• Mengeneinheit: STK